Cargando…
Evaluation of follow-up observation using human epididymis protein 4, a tumor marker, in patients with ovarian cancer
OBJECTIVE: We evaluated the usefulness of human epididymis protein 4 (HE4), a tumor marker, during and after treatment in patients with ovarian cancer (OC). METHODS: We included Japanese patients newly diagnosed with OC treated at the National Cancer Center Hospital between 2014 and 2021. The HE4 le...
Autores principales: | Uno, Masaya, Matsuo, Rie, Maezawa, Naoki, Kato, Tomoyasu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Obstetrics and Gynecology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375218/ https://www.ncbi.nlm.nih.gov/pubmed/37380167 http://dx.doi.org/10.5468/ogs.23024 |
Ejemplares similares
-
Identification of high-risk patients by human epididymis protein 4 levels during follow-up of ovarian cancer
por: STEFFENSEN, KARINA DAHL, et al.
Publicado: (2016) -
Ovarian Serous Cystadenoma of the Epididymis: A Case Report
por: Pierce, Daniel P, et al.
Publicado: (2023) -
Serum Human Epididymis Protein 4 as a Prognostic Marker in Cervical Cancer
por: Hwang, Woo Yeon, et al.
Publicado: (2022) -
Treatment strategies for patients with advanced ovarian cancer undergoing neoadjuvant chemotherapy: interval debulking surgery or additional chemotherapy?
por: Yoneoka, Yutaka, et al.
Publicado: (2019) -
Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer
por: Zhu, Liancheng, et al.
Publicado: (2015)